LLY vs JNJ
By Alex · Tickerpine
Eli Lilly and Company vs Johnson & Johnson, side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | LLY | JNJ |
|---|---|---|
| Price | $1,443.50 | $285.75 |
| Market cap | $1.29T | $687.89B |
| P/E ratio | 46.9 | 43.4 |
| ROE | 86.02% | 20.02% |
| Profit margin | 31.90% | 16.20% |
| Revenue growth | 38.60% | 5.90% |
| Dividend yield | 0.48% | 1.88% |
| Beta | 0.39 | 0.20 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
LLY vs JNJ in plain English
- LLY is the bigger company — about 1.9× the market cap of JNJ.
- JNJ is cheaper on earnings (P/E 43.4 vs 46.9).
- LLY earns a higher return on equity (86% vs 20%).
- LLY is growing revenue faster (39% vs 6%).
- JNJ has the higher dividend yield (1.88% vs 0.48%).
How would $1,000 have done in each?
LLY return calculator
See what $1,000 in Eli Lilly and Company would be worth today.
JNJ return calculator
See what $1,000 in Johnson & Johnson would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.